Reply letter to "safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance".
Hum Vaccin Immunother
; 17(11): 4115-4116, 2021 11 02.
Article
in English
| MEDLINE | ID: covidwho-1390346
ABSTRACT
In the letter, Urro et al. performed a search on the sucrose, fructose and sorbitol content in the approved Sars-Cov-2 vaccines and they concluded that these vaccines can be safely administered in adults affected by Hereditary fructose intolerance.The Pfizer-BioNTech COVID-19 Vaccine is currently approved for use in adolescents ≥ 12 years and the Moderna COVID-19 vaccine is close to approval for use in children over 12 years of age. Furthermore, both vaccines have initiated clinical trials that will include infant as young as 6 months. Therefore, we considerate important to analyze the safely administration of this two vaccines in children with Hereditary fructose intolerance.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Fructose Intolerance
/
COVID-19
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Adolescent
/
Adult
/
Child
/
Humans
/
Infant
Language:
English
Journal:
Hum Vaccin Immunother
Year:
2021
Document Type:
Article
Affiliation country:
21645515.2021.1959149
Similar
MEDLINE
...
LILACS
LIS